Modification of dendritic cell function and priming of protective immunity by malaria blood-stage parasites
Modification of dendritic cell function and priming of protective immunity by malaria blood-stage parasites
批准号:
nhmrc : 223302
负责人:
Prof Magdalena Plebanski
金额:
$21.1万
依托单位国家:
澳大利亚
项目类别:
NHMRC Project Grants
财政年份:
2003
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2003-01-01 至 2004-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Approximately 2 billion individuals live in areas where malaria is a risk. Children and naive individuals who get infected for the first time, usually travellers, are most at risk of dying from a Plasmodium falciparum infection, with an estimated 2 million children under 3 years of age killed each year. Surviving adults living in malarial areas have partial immunity after a series of infections. It is unclear how this protective immunity, particularly cellular immunity is acquired, and also unclear why it takes so long to develop. Recent advances in immunology have indicated that Dendritic Cells (DCs) are necesssary to induce effectively cellular immunity and prime memory responses. DCs take up foreign proteins and show them to T cells resulting in their activation. T cells are critical for the establishment of long-term protective immunity to malaria. However, it has not been known if DC can take up malaria parasites or malaria infected red-blood cells and process them to activate protective T cell responses. Our preliminary data shows that both human and mouse DC can take up parasitised red-cells, but that the interaction of parasite derived proteins on the surface of the red cell with DC receptors causes a defect in DC maturation. This defect may prevent effective priming of T cells during natural malaria infection, contributing to the poor development of immunity in malaria endemic areas. Given these novel fundamental findings, it is now important to elucidate: 1) The nature of the DC defect induced by the parasites 2) Assess whether this is a common feature of all Plasmodia, or whether it may relate to strain virulence 3) Determine the nature and extent of the malaria specific response induced by the defective DC. Understanding how parasites may be able to sabotage a critical inducing component of the immune system has wide implications for the use of any immuno-therapies in malaria endemic regions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Innovative immune-based therapies and diagnostics: using nanotechnology for personalized medicine
-
批准号:nhmrc : GNT1154850
-
项目类别:Research Fellowships
-
资助金额:$79.23万
-
财政年份:2019
-
负责人:Prof Magdalena Plebanski
-
依托单位:
Use novel properties of nanoparticles to engineer and progress to the clinic 2nd generation therapeutics to tackle major human diseases including cancer, malaria and asthma
-
批准号:nhmrc : GNT1059409
-
项目类别:Research Fellowships
-
资助金额:$60.14万
-
财政年份:2014
-
负责人:Prof Magdalena Plebanski
-
依托单位:
Immune imprinting by nanoparticles and vaccines: new principles and translation into the clinic
-
批准号:nhmrc : 1059409
-
项目类别:Research Fellowships
-
资助金额:$42.08万
-
财政年份:2014
-
负责人:Prof Magdalena Plebanski
-
依托单位:
Biodegradable immuno-therapeutic nanoparticles
-
批准号:DP0986357
-
项目类别:Discovery Projects
-
资助金额:$29.08万
-
财政年份:2009
-
负责人:Prof Magdalena Plebanski
-
依托单位:
Uncoupled Research Fellowship
-
批准号:nhmrc : 490977
-
项目类别:NHMRC Research Fellowships
-
资助金额:$46.04万
-
财政年份:2008
-
负责人:Prof Magdalena Plebanski
-
依托单位:
Uncoupled Research Fellowship
-
批准号:nhmrc : 223304
-
项目类别:NHMRC Research Fellowships
-
资助金额:$38.47万
-
财政年份:2003
-
负责人:Prof Magdalena Plebanski
-
依托单位:
CD38+ T cells in malaria immuno-suppression
-
批准号:nhmrc : 181614
-
项目类别:NHMRC Project Grants
-
资助金额:$13.36万
-
财政年份:2002
-
负责人:Prof Magdalena Plebanski
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Got2基因对浆细胞样树突状细胞功能的调控及其在系统性红斑狼疮疾病中的作用研究
-
批准号:82371801
-
项目类别:面上项目
-
资助金额:47.00万元
-
批准年份:2023
-
负责人:周海波
-
依托单位:
缺氧诱导因子(HIF)-2α转录抑制树突状细胞CD36表达减轻肾脏缺血再灌注损伤的机制
-
批准号:82370751
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:张明
-
依托单位:
树突状细胞(Dendritic cells,DCs)介导的黏膜免疫对猪轮状病毒(PRV)感染的分子作用机制研究
-
批准号:31272541
-
项目类别:面上项目
-
资助金额:82.0万元
-
批准年份:2012
-
负责人:王春凤
-
依托单位:
智障模型小鼠中树突棘可塑性的在体研究
-
批准号:81100839
-
项目类别:青年科学基金项目
-
资助金额:14.0万元
-
批准年份:2011
-
负责人:李威
-
依托单位:
Wnt/β-catenin信号调控耐受型DC与根尖周骨破坏
-
批准号:81170956
-
项目类别:面上项目
-
资助金额:51.0万元
-
批准年份:2011
-
负责人:彭彬
-
依托单位:
浆细胞性树突状细胞在COPD发病机制中的作用及其对Treg的影响
-
批准号:81070032
-
项目类别:面上项目
-
资助金额:32.0万元
-
批准年份:2010
-
负责人:陈雪芹
-
依托单位:
吲哚胺2,3双加氧酶抑制移植排斥反应的作用机制研究
-
批准号:81070377
-
项目类别:面上项目
-
资助金额:32.0万元
-
批准年份:2010
-
负责人:戴向晨
-
依托单位:
Jagged2high CD11bhigh 调节性树突状细胞防治cGVHD的实验研究
-
批准号:30972790
-
项目类别:面上项目
-
资助金额:28.0万元
-
批准年份:2009
-
负责人:杜欣
-
依托单位:
警报素(alarmin)HMGN1作为DNA疫苗佐剂的应用基础研究
-
批准号:30901376
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2009
-
负责人:魏枫
-
依托单位:
Endoglin基因修饰肿瘤/DC杂交细胞诱生靶向特异性抗人肺癌CTL疫苗的研究
-
批准号:30760248
-
项目类别:地区科学基金项目
-
资助金额:16.0万元
-
批准年份:2007
-
负责人:周源
-
依托单位: